MarketResearch.biz delivers in-depth insights on the global controlled release drug delivery market in its upcoming report titled, “Global Controlled Release Drug Delivery Market Trends, Applications, Analysis, Growth, and Forecast: 2018 to 2027”. The global controlled release drug delivery market is estimated to register a CAGR of X.X% in terms of value during forecast period 2018–2027. The report offers in-depth insights, revenue details, and other vital information regarding the target market, and the various trends, drivers, restraints, opportunities, and threats till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global controlled release drug delivery market report has been segmented on the basis of technology, mechanism, application, and region.
Controlled release drug delivery system is used to release drug at a desired rate over a certain period of time which helps to maintain the therapeutic level in blood. Controlled release drug delivery system is very helpful in increasing efficiency of dose as well as meet patient compliance.
Advancements in drug delivery systems that is mechanically strong, comfortable for patient, and capable of achieving high drug loading and increasing demand from pediatric and geriatric population for easy administration of medicines/ drugs are major factors driving growth of the global controlled release drug delivery market. In addition, controlled release drug delivery having various advantages such as reduction in drug accumulation with chronic therapy, reduced drug toxicity, stabilization of medical condition due to more uniform drug levels, etc., which is another factor expected to boost growth of the global controlled release drug delivery market.
However, potential disadvantages such as possible toxicity or non-biocompatibility of the materials used is expected to hamper growth of the global controlled release drug delivery market. In addition, high cost of controlled release systems compared to traditional pharmaceutical formulations is expected to challenge growth of the global controlled release drug delivery market to certain extent.
Increasing investment and R&D activities by prominent players for development of cost effective controlled release drug delivery is expected to present new opportunities to players operating in this market over the forecast period.
North America market is expected to dominate in the global controlled release drug delivery market with higher revenue share as compared to other regional markets, owing to increasing government initiatives for development of controlled release drug delivery, presence of prominent market players in this region. Europe market accounts for second-largest revenue share in the global controlled release drug delivery market followed by markets in Asia Pacific, Latin America and Middle East & Africa respectively. The market in Asia Pacific is projected to witness fastest growth in terms of revenue. This can be attributed to increasing pharmaceutical infrastructural activities and increasing investment and R&D activities by pharmaceutical and biopharmaceutical companies in countries in this region.
Global Controlled Release Drug Delivery Market Segmentation:
- Wurster Technique
- Micro Encapsulation
- Targeted Delivery
- Others (Microelectromechanical Technology, Liposomes)
By Release Mechanism:
- Polymer Matrix Based Systems
- Micro Reservoir Partition Controlled Drug Delivery Systems
- Feedback Regulated Drug Delivery Systems
- Activation-modulated Drug Delivery Systems
- Chemically Activated
- Metered Dose Inhalers
- Transdermal and Ocular Patches
- Infusion Pumps
- Oral Controlled-Drug Delivery Systems
- Drug Eluting Stents
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
- Depomed, Inc.
- Coating Place, Inc.
- Corium International, Inc.
- Johnson and Johnson
- Alkermes plc
- Pfizer, Inc.
- Orbis Biosciences, Inc.
- Capsugel Inc.
- Merck and Co., Inc.
- Aradigm Corporation
Request for TOC
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
Request for Customization
Don't just take our word. We are trusted by these great companies!